Last reviewed · How we verify

NCT06181747

Development of Attention and Its Relationship With Emotions in Children and Adolescents

Completed NA Last updated 1 March 2024
What this trial tests

NA trial testing a serious mobile device-based game prototype (Save the Muse Home) in Attention Deficit Disorder With Hyperactivity in 110 participants. Completed in 10 May 2023.

Timeline
1 March 2023
Primary endpoint
5 May 2023
10 May 2023

Quick facts

Lead sponsorInstitute of Psychology, Chinese Academy of Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment110
Start date1 March 2023
Primary completion5 May 2023
Estimated completion10 May 2023
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Institute of Psychology, Chinese Academy of Sciences

Who can join

Adults 6 to 12, any sex, with Attention Deficit Disorder With Hyperactivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our aim was to describe the development and usability of a mobile device-based game therapy software for ADHD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A mobile device-based game prototype for ADHD: development and preliminary feasibility testing.
    Luo J, Li F, Wu Y, Liu X, et al · · 2024 · cited 1× · PMID 38858375 · DOI 10.1038/s41398-024-02964-2

Verify or expand the search:

Other recruiting trials for Attention Deficit Disorder With Hyperactivity

Currently open trials in the same condition.

Other Institute of Psychology, Chinese Academy of Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06181747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing